过去一年中添加的文章，按日期排序
[引用][C] Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens
S Ikeda, T Kinoshita - Psychiatry and Clinical Neurosciences …, 2024 - Wiley Online Library
30 天前 - … disorder (PMDD) may benefit. Marijuana derives from … been approved for the
treatment of treatment‐resistant … escitalopram, a selective serotonin reuptake inhibitor, over …
treatment of treatment‐resistant … escitalopram, a selective serotonin reuptake inhibitor, over …
… of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and …
…, A Metelli, G Michencig, A Miuli, A Moncada… - …, 2024 - thelancet.com
121 天前 - … might be a promising alternative to selective serotonin … The intention-to-treat
population included 179 individuals … Additionally, hypothetical advantages of vortioxetine on …
population included 179 individuals … Additionally, hypothetical advantages of vortioxetine on …
[HTML][HTML] Novel rapid treatment options for adolescent depression
S Ledesma-Corvi, J Jornet-Plaza… - Pharmacological …, 2024 - Elsevier
135 天前 - … , since the selective serotonin reuptake inhibitors that are … , and/or other factors that
might affect efficacy or long-term … to exert the most beneficial treatment outcome in terms of …
might affect efficacy or long-term … to exert the most beneficial treatment outcome in terms of …
[HTML][HTML] Additional cognitive behavior therapy for persistent postural-perceptual dizziness: a meta-analysis
J Zang, M Zheng, H Chu, X Yang - Brazilian Journal of Otorhinolaryngology, 2024 - Elsevier
144 天前 - … , Serotonin-Noradrenaline Reuptake Inhibitors (SNRIs) … and after treatment,
indicating that additional CBT provided … therapy may provide significant benefits compared with …
indicating that additional CBT provided … therapy may provide significant benefits compared with …
Pharmacogenomics and major depressive disorder: time to take a stance?
NR Boivin, H Jusufi - Pharmacogenetics and Genomics, 2024 - journals.lww.com
170 天前 - … including selective serotonin reuptake inhibitors, serotonin… may benefit from improved
medication targeting provided … testing can be beneficial for guiding management in MDD …
medication targeting provided … testing can be beneficial for guiding management in MDD …
Psychedelic Therapy: A Primer for Primary Care Clinicians–Part I. Historical Perspective and Overview
BJ Tabaac, K Shinozuka, A Arenas, BD Beutler… - 2023 - europepmc.org
173 天前 - … not benefited from … it may not be more effective than antidepressants.Therapeutic
Advances: Esketamine, a dissociative hallucinogen drug, was approved for the management …
Advances: Esketamine, a dissociative hallucinogen drug, was approved for the management …
[图书][B] Mental illness in chronic kidney disease: prognosis, drug utilization, and treatment outcomes
N Zhu - 2023 - openarchive.ki.se
188 天前 - … Notably, antidepressants may have different risk-benefit … providing evidence to
support treatment decision-making. … , and selective serotonin-reuptake inhibitors (SSRIs). The …
support treatment decision-making. … , and selective serotonin-reuptake inhibitors (SSRIs). The …
Gardeniae Fructus and Its Prescriptions in Treatment of Depression: A Review
L TIAN, Y LI, M BAI, B WANG… - Chinese Journal of …, 2023 - pesquisa.bvsalud.org
199 天前 - … antidepressants, and selective serotonin reuptake … , has unique advantages in
the prevention and treatment of … The mechanism of action may be related to regulating the …
the prevention and treatment of … The mechanism of action may be related to regulating the …
SSRIs in the Treatment of Depression: A Pharmacological CUL-DE-SAC?
PJ Cowen - 2023 - Springer
225 天前 - … of selective serotonin reuptake inhibitors (SSRIs) as first-line pharmacological
treatments in the management of … benefits; however, vortioxetine may provide more utility in the …
treatments in the management of … benefits; however, vortioxetine may provide more utility in the …
Pharmacological treatments for anxiety, obsessive-compulsive and post-traumatic stress disorder: a meta-regression and multilevel network meta-analysis
NP Gosmann - 2023 - lume.ufrgs.br
225 天前 - … to treatments with selective serotonin reuptake inhibitors (… analyses allow for the
identification of subgroups that may … This study improved the evidence of the benefit of SSRIs …
identification of subgroups that may … This study improved the evidence of the benefit of SSRIs …